Correlation Between Response Oncology and Morgan Stanley

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Response Oncology and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Response Oncology and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Response Oncology and Morgan Stanley, you can compare the effects of market volatilities on Response Oncology and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Response Oncology with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Response Oncology and Morgan Stanley.

Diversification Opportunities for Response Oncology and Morgan Stanley

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Response and Morgan is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Response Oncology and Morgan Stanley in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley and Response Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Response Oncology are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley has no effect on the direction of Response Oncology i.e., Response Oncology and Morgan Stanley go up and down completely randomly.

Pair Corralation between Response Oncology and Morgan Stanley

If you would invest (100.00) in Response Oncology on September 20, 2024 and sell it today you would earn a total of  100.00  from holding Response Oncology or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Response Oncology  vs.  Morgan Stanley

 Performance 
       Timeline  
Response Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Response Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Response Oncology is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Morgan Stanley 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Morgan Stanley unveiled solid returns over the last few months and may actually be approaching a breakup point.

Response Oncology and Morgan Stanley Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Response Oncology and Morgan Stanley

The main advantage of trading using opposite Response Oncology and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Response Oncology position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.
The idea behind Response Oncology and Morgan Stanley pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators